Introduction
Implantable cardioverter defibrillator (ICD) use has been shown to reduce mortality among patients with heart failure and left ventricular systolic dysfunction [1e6] . However, up to 13% of patients who receive an ICD can receive inappropriate shocks and as much as 31% of total shocks delivered by ICDs are considered inappropriate [7, 8] . Nearly 80% of inappropriate ICD shocks are caused by supraventricular tachycardia (SVT), which includes atrial fibrillation (AF), atrial flutter, sinus tachycardia, atrial tachycardia, atrioventricular (AV) reentrant tachycardia, and AV nodal reentrant tachycardia (AVNRT) [8] . AF is known to be a common cause of ICD therapies, but the rhythm irregularity and other factors facilitate fairly accurate discrimination and avoidance of ICD shocks via device programming [8e10] . At the same time, all SVT entities with the exception of AF can exist with a 1:1 A-V relationship, thereby presenting a potential diagnostic challenge.
Discrimination of ventricular tachycardia (VT) from such arrhythmias is believed to be facilitated by the presence of dual-chamber detection [11, 12] . However, the Centers for Medicare & Medicaid Services does not reimburse the addition of an atrial lead for that purpose alone in patients who have no documented SVT prior to device implantation [13] , because there is evidence that SVT-induced ICD shocks can be avoided just as successfully with a single lead device and optimal device programming [14e16] . Furthermore, implanting an atrial lead solely for that purpose adds unnecessary risk to the procedure, particularly dislodgement, perforation, and vascular injury [17e19] .
It is in that context that the FDA recently approved a novel ICD lead that enables two-chamber sensing without requiring a separate atrial lead [20] . Herein we present a patient who received an ICD using such a lead but nevertheless experienced inappropriate ICD shocks secondary to SVT, consistent with typical slow-fast AVNRT. This case inspired a literature review of the discrimination mechanisms designed to differentiate SVT with a 1:1 relationship from ventricular tachycardia (VT) with 1:1 retrograde conduction.
Case report
A 57-year-old man with non-ischemic dilated cardiomyopathy and an ejection fraction of 20% for several years despite optimal medical management received an ICD for primary prevention of sudden cardiac death. The implanted device employed a single lead with atrial sensing capabilities (BIOTRONIK Lumax 740 VR-T DX, BIOTRONIK SE & Co KG, Berlin, Germany). Of note, although he had experienced palpitations in the past, at the time of device implantation he had no documented history of tachyarrhythmias. Several months after the implant, he presented to the electrophysiology clinic with recurrent ICD shocks. The patient reported multiple episodes of palpitations and lightheadedness, several of which were terminated by ICD shocks. On these occasions, he was fully conscious when shocked and was clearly emotionally impacted by the events, as he was now complaining of fear, anxiety, and a sense of impending doom. Device interrogation revealed multiple episodes of tachycardia with a fast ventricular rate (205e225 bpm), a 1:1 V-A relationship, and a V-A time of 50 ms (msec) (Fig. 1) . In several cases, antitachycardia pacing (ATP) was able to successfully terminate the arrhythmia (Fig. 2) . At other times, despite ventricular capture, ATP was unable to entrain the tachycardia. In those instances, the tachycardia persisted after ATP (Fig. 3) . On two occasions, the tachycardia fell into the ventricular fibrillation (VF) zone, resulting in ICD shocks. Table 1 illustrates the device settings at the time of shock.
A diagnosis of AVNRT was strongly suspected on the retrospective review of the tachycardia episode, based on the short V-A time, the unchanged ventricular morphology on intracardiac electrograms, and the response to ATP. The patient was, therefore, scheduled for an electrophysiology (EP) study and possible radiofrequency catheter ablation. Meanwhile, in order to avoid further inappropriate shocks while awaiting the EP study, the VF zone was increased to greater than 233 bpm. At the EP study, dual AV nodal physiology was in fact revealed. A narrow complex tachycardia was reproducibly induced with single atrial extra-stimuli (Fig. 4) . The tachycardia had a 1:1 VA relationship, a negative V-A time, and concentric atrial activation. Entrainment maneuvers were consistent with typical AVNRT. Slow pathway modification was performed, following which tachycardia was no longer inducible. Post-ablation, the device settings were returned to the primary prevention settings standard for our practice. On follow-up device interrogations, there have been no further episodes of tachycardia. The patient is relieved, but states that the anxiety caused by this experience has not completely resolved.
Discussion
The aim of this analysis is to highlight potential difficulties in device discrimination of non-AF SVT from VT and to review what is known about existing options to prevent inappropriate treatment in such cases. The negative consequences of inappropriate shocks are several-fold. A single inappropriate shock results in increased mortality, with a hazard-ratio (HR) of 1.6. The risk further increases with each subsequent shock until up to a HR of 3.7 after 5 inappropriate shocks [7] . Significant behavioral disorders, psychological distress, and a negative impact on quality of life have also been described following ICD shocks [21e24]. Furthermore, inappropriate shocks are pro-arrhythmic and have the potential to cause malignant ventricular arrhythmias [25, 26] . Finally, they also lead to more frequent clinic visits and hospitalizations, with a subsequent increase in healthcare costs [27, 28] .
An observational analysis of 426 patients reported that 13.6% of inappropriate ICD shocks were attributed to AVNRT; the incidence of AVNRT among ICD recipients was approximately 3.5% [29] . Current multi-society guidelines give a Class I indication to catheter ablation for the treatment of symptomatic AVNRT [30] . Catheter ablation targeting the slow pathway of the AV node has a success rate greater than 95%, with a risk of heart block requiring pacemaker implantation of only about 1% [31, 32] . In other words, identifying ICD patients with AVNRT has the potential to reduce or eliminate inappropriate shocks, thereby improving patients' quality of life and possibly even their survival.
The commercially available algorithms used to discriminate SVT from VT differ depending on whether dual-or single-chamber sensing is available. In single-chamber sensing, the most used criteria are electrogram morphology, interval stability, and suddenness of onset. Both AVNRT and VT with 1:1 VA conduction typically have a sudden onset and high interval stability. Therefore, in single-chamber sensing, electrogram morphology is the only criterion capable of i n d i a n p a c i n g a
discriminating between VT and abrupt-onset regular SVTs, such as AVNRT. While this distinction can be easily made in the setting of "normal" conduction, it is not uncommon for AVNRT to be associated with rate-related bundle branch block, thereby removing the usefulness of electrogram morphology [10] .
In dual-chamber sensing, additional criteria for SVT-VT distinction include comparison of atrial and ventricular rates, 
AV association, and P:R pattern. [10] More than 90% of VTs are identified by a ventricular rate > atrial rate [10] . However, up to 20% of patients with VT demonstrate retrograde conduction and thus have the potential to develop VT with 1:1 retrograde conduction [33, 34] . As in AVNRT, VT with 1:1 VA conduction presents with AV association and equal atrial and ventricular rates. Therefore, the distinction between AVNRT and VT with 1:1 VA conduction is highly dependent on timing relationships between atrial and ventricular electrograms, which is called P:R pattern analysis [10] . The V-A interval, measured from the onset of ventricular depolarization to the subsequent earliest demonstration of atrial activation, is used to characterize the P:R pattern [35] . Atrial and ventricular conduction occur almost concurrently in AVNRT; the V-A interval is therefore shorter than in VT [35] . Indeed, the V-A interval is typically longer than 80 msec in VT with retrograde conduction [36] . In the patient we present here, therefore, the V-A time of 50 msec is consistent with AVNRT.
While the use of V-A interval is obviously crucial in distinguishing between AVNRT and VT, it may not be sufficient for discrimination. Given the importance of atrial sensing in dual-chamber discriminators and the increased sensitivity required to detect low-amplitude atrial electrograms, there is a potential for oversensing of far-field R wave signals and subsequent overestimation of the atrial rate [10, 37] . This phenomenon may lead to inappropriate rejection of VT as SVT or vice versa [10,38e40] . To prevent atrial oversensing of farfield R waves, some dual-chamber ICDs have a postventricular atrial blanking period, in which the atrial lead is unable to sense any events for up to 200 ms [10, 41] . Undersensing of atrial events in the blanking period also has the potential to cause inappropriate shocks, because the ventricular rate can be mistakenly identified as greater than the atrial rate [10, 14, 41] . In fact, in the case here presented, atrial events were not recognized by the device, as they occurred within the postventricular blanking period. Thus, the ventricular rate was interpreted as greater than the atrial rate, and VT was (mistakenly) recognized.
Atrial undersensing (and misclassification of tachycardia as ventricular rate > atrial rate) is a major limitation of dual- i n d i a n p a c i n g a
chamber ICDs, and may be accountable for the absence of benefit in avoiding inappropriate therapies when compared to single-chamber devices. In a randomized trial comparing single to dual-chamber ICDs, 75% of inappropriate therapies in the dual-chamber group were secondary to atrial sensing problems, mostly undersensing [15] . Manufacturers have developed different strategies to overcome the challenges of setting the post-ventricular atrial blanking period. In Biotronik SMART algorithm, the blanking period can be adjusted to a minimal value, in which case sensing of atrial events is not affected, thereby enabling accurate determination of the atrial rate and the V-A interval [42] . A similar option is available in St. Jude Medical and Boston Scientific devices [43] . The Medtronic PR Logic and ELA/Sorin algorithms maintain atrial sensing during the PVAB for the purpose of SVT-VT discrimination. When a 2:1 AV rhythm is identified, these algorithms analyze A-V and V-A intervals to reject far-field R waves and therefore prevent atrial oversensing [43] . Different manufacturers use the various discriminators in distinct sequences to establish an algorithm for VT/SVT discrimination. The DX Biotronik ICD system utilizes the SMART algorithm (Fig. 5) , which includes heart rate, interval stability, A:V association, and P:R pattern analysis. Atrial and ventricular rates are analyzed first. If the ventricular rate is faster (Fig. 5, line 1) , the rhythm is classified as VT. If the atrial rate is faster (Fig. 5, line 2) , the rhythm is identified as SVT if either the RR is unstable (suggests variable AV conduction) or the A/V relationship shows an integral conduction ratio (e.g., 2:1, 3:1). If the ventricular and atrial rates are equal (Fig. 5, line  3) , the system checks for stability and association. If the RR is stable but the PP is not, there is AV dissociation and VT is identified. If both RR and PP are stable, the rhythm is classified as VT if either the PR changes (AV dissociation) or if there is suddenness of onset. If the RR is unstable, a stable PR (AV association) indicates SVT, whereas an unstable PR (AV dissociation) indicates VT [44] . As shown in the bold sequence of Fig. 5 , this algorithm cannot reliably differentiate AVNRT from VT with retrograde 1:1 conduction, given that both arrhythmias present with equal atrial and ventricular rates, stable RR and PP intervals (stability), no PR change (AV association), and sudden onset. In this particular sequence, the SMART system identifies VT. Therefore, the electrophysiologist should have increased awareness of the possibility of AVNRT and apply the concepts discussed here to successfully discriminate this potentially curable arrhythmia.
Unlike the SMART system, St. Jude Medical, Boston Scientific Rhythm ID, and Medtronic PR Logic algorithms utilize morphology assessments to discriminate SVT from VT [45] . In Medtronic devices that utilize PR Logic, SVT-VT discrimination can still occur in the VF zone. PR Logic uses three patterns of discriminators to identify SVTs ( Table 2) . Each of these rules is individually programmable and can be turned off. As in other dual-chamber sensing algorithms, a ventricular rate faster than the atrial rate identifies VT. If the rhythm cannot be classified as VT based on rates, and none of the three SVT rules can be identified, PR Logic applies morphologic criteria for discrimination. This is done by checking for concordance between the unknown tachyarrhythmia and the baseline ventricular depolarization morphology [45e47] .
In addition to the previously mentioned V-A interval, the response to ATP may also help in discriminating AVNRT from VT with retrograde 1:1 conduction. Overdrive pacing by ATP with a cycle length (CL) that is slightly shorter than the tachycardia CL can lead to one of three responses in AVNRT. Entrainment occurs when pacing is able to continuously reset the full tachycardia circuit with each paced beat. In entrainment, the atrial CL exactly matches the paced CL (Fig. 2) . AV dissociation develops when ventricular capture occurs, but the nodal tachycardia circuit is maintained; in this case, the ventricular CL matches the paced rhythm, but the atrial CL remains unchanged from the original tachycardia. Finally, termination of AVNRT by ATP is also a possibility. Up to 20% of SVTs can be terminated by ATP [48e50]. Termination and entrainment also occur in VT; therefore, these responses to ATP cannot reliably discriminate AVNRT from VT with 1:1 VA conduction [51, 52] . However, maintenance of the same tachycardia CL in the atria after ATP ventricular capture (AV dissociation; Fig. 3 ) and after ATP is finished demonstrates that atrial depolarization during the tachycardia is independent of ventricular origin. Thus, this finding excludes the possibility of VT with 1:1 retrograde conduction and atrioventricular reentrant tachycardia using a usual atrioventricular accessory pathway. In VT with retrograde 1:1 conduction, when ATP ventricular capture occurs, the CL in the atria either (1) follows the CL of the ventricular paced rhythm (if entrainment occurs), or (2) returns to a sinus/atrial paced rhythm if the paced stimuli are unable to reach the atria. The CL in the atria cannot, however, remain the same as the tachycardia CL, given that atrial depolarization arises from a ventricular stimulus in VT with 1:1 VA conduction.
Importantly, RR intervals falling into the ventricular fibrillation (VF) zone are not considered for discrimination by the Biotronik SMART algorithm. At ventricular rates >200e230 bpm, distinction between VF and SVT is not accurate due to the following: (1) RR intervals in AF can become more regular [53] ; (2) both VF and rapidly conducting AF present with AV dissociation [38] ; and (3) irregular RR intervals are also observed in polymorphic VT and VF, which could i n d i a n p a c i n g a
potentially misclassify the rhythm as SVT [10] . Interestingly, up to 42% and 10% of ICD therapies for ventricular arrhythmias occur at rates > 188 bpm and >250 bpm, respectively, and thus have the potential to fall under the VF zone [54] . Ricci et al. showed that 50% of AF-related inappropriate shocks occur at rates >200 bpm [55] . The concern for VF zone inappropriate ICD therapy in SVT is particularly worrisome in younger patients with rapidly conducting AV nodes, where the heart rate can reach nearly 250 bpm [29, 56] . The patient in our case had received 2 ICD shocks for SVT with rates in the VF zone.
Conclusion
Differentiating SVT from VT in patients with ICDs is important in the optimization of clinical outcomes, but this can be challenging in rhythms with a 1:1 VA relationship. Programming of the post-ventricular atrial blanking period can result in undersensing of atrial activity (long PVABP) or oversensing of far-field R waves as atrial activity (short PVABP), which can misclassify a 1:1 rhythm into ventricular rate > atrial rate, or vice-versa, respectively. Setting dual-chamber devices to a minimal blanking period can allow accurate sensing during the refractory period and precise determination of the V-A interval, which can be extremely useful in distinguishing AVNRT (short V-A interval) from VT with 1:1 retrograde conduction. The response to ATP may also assist in discriminating such arrhythmias. Particularly, the persistence of the tachycardia CL in the atria concomitantly with ATP ventricular capture (AV dissociation) is highly suggestive of AVNRT. Catheter ablation is a class I indication for the treatment of symptomatic AVNRT. Inappropriate shocks due to AVNRT in patients with ICDs provide further support for this potentially curative treatment. In this scenario, the procedure has the added benefit of preventing further inappropriate shocks and their negative consequences.
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